obeticholic acid
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 11, 2024
Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
(clinicaltrials.gov)
- P3 | N=108 | Completed | Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Recruiting ➔ Completed | N=156 ➔ 108
Enrollment change • Trial completion • Hepatology • Immunology • Primary Biliary Cholangitis
July 06, 2023
Advances in Treatment of Primary Biliary Cholangitis (PBC) : Episode 10: Current Treatments for PBC
(HCPLive)
- "Experts reviews the current treatment landscape for management of PBC, highlighting ursodeoxycholic acid (UDCA) and obeticholic acid (OCA), as well as liver transplant."
Video
1 to 2
Of
2
Go to page
1